Semisynthetic cephalosporins. IV. Synthesis and structure activity relationships of parenterally active 7-[4-(substituted methyl)phenyl]-acetamido-3-cephem-4-carboxylic acids. 1981

A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson

A group of novel 4-substituted phenylacetic acids were prepared and coupled with several 7-amino-delta-3-cephems to afford a family of parenterally active cephalosporins. A compound designated 13I had the broadest spectrum of activity and the highest potency of the group against both Gram-positive and Gram-negative bacteria. The activity of 13I included high potency against penicillinase-producing staphylococci and activity against anaerobes, including Bacteroides fragilis.

UI MeSH Term Description Entries
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
January 1980, The Journal of antibiotics,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
June 1976, Journal of medicinal chemistry,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
January 1974, Journal of medicinal chemistry,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
February 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
February 1993, The Journal of antibiotics,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
October 1981, The Journal of antibiotics,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
November 2011, Acta crystallographica. Section E, Structure reports online,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
December 1989, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
April 1990, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
A Nudelman, and F Haviv, and A Patchornick, and E Karoly-Hafely, and F Braun-Bucholts, and B Kaier, and J Itzchaki, and S Sasson, and R C Erickson
May 1983, The Journal of antibiotics,
Copied contents to your clipboard!